No Cure yet for HIV ...GAC Urges Strict Adherence to Treatment
Uganda received nearly 20,000 doses, but clinics have run out as advocates warn the $28,000 price and limited supply will slow access.
5 Articles
5 Articles
The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews
It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But questions are being raised about getting it to the areas that need it most.
No cure yet for HIV ...GAC urges strict adherence to treatment
The Ghana AIDS Commission (GAC) has reiterated that there is still no cure for HIV, urging persons diagnosed with the disease to remain on antiretroviral (ARV) treatment to suppress the virus and live long with healthy lives. It said although antiretroviral therapy (ART) was highly effective, Ghana’s treatment coverage remained low, with only 57 per cent of the estimated 337,435 persons living with HIV (PLHIV), currently on treatment. The Direct…
Barriers and facilitators to adherence of infants living with HIV in sub-Saharan Africa in an era of wide access to ART: a mixed-methods study
Authors: Peay HL, Kruger S, Otwombe K, Boene H, Lain MG, Ngwenya N, Domínguez-Rodríguez S, Barnabas SL, Bingaman A, Kunene M, Giaquinto C, Henderson GE, Madiehe F, The post Barriers and facilitators to adherence of infants living with HIV in sub-Saharan Africa in an era of wide access to ART: a mixed-methods study first appeared on Penta.
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
